The Interventional Oncology market size is USD 2.2 Bn in 2026.
The Interventional Oncology market is projected to grow at a CAGR of 6% by 2033.
The Interventional Oncology market growth drivers include rising preference for minimally invasive procedures, increasing incidence of liver and other cancers, and adoption of advanced technologies like AI and robotics.
Asia Pacific is a dominating region for Interventional Oncology market.
Medtronic plc, Boston Scientific Corporation, Siemens Healthineers, GE Healthcare, and Philips Healthcare are some leading industry players in the Interventional Oncology market.